Cartesian Therapeutics (RNAC) Enters $130M Private Placement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
Oppenheimer Downgrades Cartesian Therapeutics (RNAC) to Perform
July 2, 2024 11:27 AM EDTOppenheimer analyst Matthew Biegler downgraded Cartesian Therapeutics (NASDAQ: RNAC) from Outperform to Perform.
The analyst comments "Weve been bullish on this nameand while the topline results looked excellent at first glance, we just cant get over the ITT versus per protocol... More
